cyclopentane has been researched along with Amnesia-Memory Loss in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Li, K; Wang, J; Wang, Q; Wang, Y; Xie, S; Zhao, J; Zuo, Z | 1 |
| Auclair, AL; Bardin, L; Bruins Slot, L; Colpaert, F; Depoortère, R; Kleven, MS; Newman-Tancredi, A; Vacher, B | 1 |
2 other study(ies) available for cyclopentane and Amnesia-Memory Loss
| Article | Year |
|---|---|
Enhanced anti-amnestic effect of donepezil by Ginkgo biloba extract (EGb 761) via further improvement in pro-cholinergic and antioxidative activities.
Topics: Acetylcholinesterase; Amnesia; Animals; Antioxidants; Behavior, Animal; Brain; Cell Line; Cholinergic Agents; Cognitive Dysfunction; Cyclopentanes; Disease Models, Animal; Donepezil; Drug Therapy, Combination; Furans; Ginkgo biloba; Ginkgolides; Humans; Male; Malondialdehyde; Maze Learning; Nootropic Agents; Plant Extracts; Rats, Wistar; Superoxide Dismutase | 2021 |
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
Topics: Amnesia; Animals; Antipsychotic Agents; Behavior, Animal; Benzofurans; Benzylamines; Cognition Disorders; Cyclopentanes; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Models, Animal; Phencyclidine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Receptors, Dopamine D4; Reflex; Reflex, Startle; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists | 2007 |